Compounds > boswellic acid
Page last updated: 2024-09-05

boswellic acid and bibw 2992

boswellic acid has been researched along with bibw 2992 in 1 studies

Compound Research Comparison

Studies
(boswellic acid)		Trials
(boswellic acid)		Recent Studies (post-2010)
(boswellic acid)		Studies
(bibw 2992)		Trials
(bibw 2992)		Recent Studies (post-2010) (bibw 2992)
227151471,0441471,007

Protein Interaction Comparison

ProteinTaxonomyboswellic acid (IC50)bibw 2992 (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.0361
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)0.0168
Cytochrome P450 1A2Homo sapiens (human)0.037
Cytochrome P450 2E1Homo sapiens (human)0.014
Cytochrome P450 2C8Homo sapiens (human)0.037
Receptor tyrosine-protein kinase erbB-3Homo sapiens (human)0.0007
Cytochrome P450 2C19Homo sapiens (human)0.037
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.0016
Receptor tyrosine-protein kinase erbB-4Homo sapiens (human)0.0024

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armenia, E; Aurilio, C; Barbarisi, A; Barbarisi, M; Botti, G; De Sena, G; Iaffaioli, RV; Libutti, M; Maurea, N; Quagliariello, V1

Other Studies

1 other study(ies) available for boswellic acid and bibw 2992

ArticleYear
Boswellic acid has anti-inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells.
    Phytotherapy research : PTR, 2019, Volume: 33, Issue:6

    Topics: Afatinib; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Boswellia; Cardiotonic Agents; Cell Line, Tumor; Chemokine CXCL12; ErbB Receptors; Glioblastoma; Humans; Interleukin-6; Interleukin-8; Leukotriene B4; Lipid Peroxidation; Myocytes, Cardiac; Reactive Oxygen Species; Temozolomide; Transcription Factor RelA; Triterpenes

2019